GlobeNewswire by notified

Interim Report Q3 2022

Share

Company announcement no. 29/2022

Solid organic growth despite macro-economic uncertainty

”Despite rapid changes in the macro-economic environment, we delivered a satisfactory Q3 driven by immense effort in all our Business Lines and Market Units. We will continue to focus on increasing efficiency to improve EBITDA margin further”, says CEO & President Søren Krogh Knudsen.

Q3 2022 highlights

  • Revenue growth of 9% amounting to DKK 334m
  • EBITDA amounts to DKK 16m
  • Efficiency of 61% in a quarter with summer vacation
  • Our new CFO Brian Iversen joined Columbus
  • Merge of Project and Care Business Lines
  • Pricing and cost initiatives start materializing
  • Launch of new sustainability strategy

Q3 2022 YTD highlights

  • Revenue growth of 7% amounting to DKK 1,117m
  • EBITDA amounted to DKK 62m which is on par with 2021
  • Pricing and cost initiatives initiated
  • Improved efficiency
  • Stable number of employees

Service revenue split on Business Lines

DKK ´000Q3 2022Q3 2021∆%YTD 2022YTD 2021∆%
Dynamics144,764134,7947.4%477,382466,6112.3%
M369,97556,38424.1%230,516219,5715.0%
Digital Commerce40,26131,23328.9%133,448112,68418.4%
Data & Analytics13,4448,92850.6%44,04625,91070.0%
Customer Experience & Engagement9,8513,992146.8%33,91620,55265.0%
Other Local Business15,96714,37811.1%52,38946,48912.7%
Total sale of services294,262249,70917.8%971,697891,8179.0%
Total sale of products 40,02657,114-29.9%145,143155,377-6.6%
Total net revenue334,288306,8239.0%1,116,8401,047,1946.7%

Service revenue split on Market Units

DKK ´000Q3 2022Q3 2021∆%YTD 2022YTD 2021∆%
Sweden107,67687,56623.0%388,521348,98211.3%
Denmark58,56656,4413.8%185,056184,6320.2%
Norway55,78945,46422.7%193,051170,85113.0%
UK41,08534,10120.5%119,153107,25011.1%
US21,20919,8596.8%59,47258,9660.9%
Other9,0205,73857.2%23,57719,26222.4%
GDC91754069.8%2,8671,87453.0%
Total sale of services294,262249,70917.8%971,697891,8179.0%
Total sale of products 40,02657,114-29.9%145,143155,377-6.6%
Total net revenue334,288306,8239.0%1,116,8401,047,1946.7%

Outlook updated
On 14 November 2022, the financial full-year guidance for 2022 was updated to:

  • Revenue guidance is specified to DKK ~1,525m, a growth of 8%.
  • EBITDA is adjusted to DKK ~100m, a growth of 12%.

Live webcast and conference call
Columbus is hosting a live webcast and conference call on 15 November 2022 at 13:00 CET. The webcast is hosted by CEO & President Søren Krogh Knudsen and Group CFO Brian Iversen.

Webcast: Please login to the webcast via Columbus’ investor site where you can follow the presentation and submit your written questions during the call: https://ir.columbusglobal.com/calendar-and-events

Conference call:

1. Participants are required to register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial In Numbers, and a unique Personal PIN.

2. In the 10 minutes prior to call start time, Participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the call me feature instead of dialling the nearest dial in number.

Online Registration to the call: https://register.vevent.com/register/BI3e618cd2995c47cdba12a227050ec52a

For further information, please contact:

  • Søren Krogh Knudsen, CEO & President, Tel.: +45 7020 5000
  • Tine Rasmussen, Communication Director, TRA@columbusglobal.com, Tel.: +45 2969 0677

About Columbus 
Columbus is a global IT services and consulting company specialized in digital transformation. Our more than 1,550+ digital explorers collaborate with our customers in the manufacturing, retail & distribution, and food & process industries. We advise, implement and manage business critical solutions within Strategy & Change, Customer Experience, Digital Commerce, Data & Analytics, Application Management and Cloud ERP. Headquartered in Denmark, we have offices and partners worldwide - delivering locally on a global scale.www.columbusglobal.com. Columbus A/S is listed on Nasdaq Copenhagen – COLUM

For more information visit www.columbusglobal.com.


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 20228.12.2022 22:30:00 CET | Press release

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of sharesTotal number of voting rights11/30/2022 94,137,145 Total gross of voting rights: 94,137,145 Total net* of voting rights: 93,966,891 * Total net = total number of voting rights attached to shares – shares without voting rights Attachment PDF Version

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants8.12.2022 22:00:00 CET | Press release

Company announcement – No. 57 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. December 8, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 64,919 divided into 64,919 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs. Employee warrant programs are part of Zealand Pharma’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a prespecified price, the exercise price, in specific predefined time periods before expiration. For a more detailed description of Zealand Pharma’s warrant programs, see the company’s Articles o

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such8.12.2022 21:40:00 CET | Press release

COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1.Details of the person discharging managerial responsibilities/person closely associateda)NamePaul Chaplin2.Reason for the notificationa)Position/status President and Chief Executive Officer of Bavarian Nordic A/S b)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Identification codeWarrants DK0015

Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer8.12.2022 21:40:00 CET | pressemeddelelse

KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende medarbejdere og/eller personer/firmaer der er nærtstående til disse. 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnPaul Chaplin2.Årsag til indberetningena)Stilling/titelAdministrerende direktør i Bavarian Nordic A/Sb)Første indberetning/ændringFørste indberetning3.Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførendea)NavnBavarian Nordic A/Sb)LEI-kode2138006JCDVYIN6INP514.Nærmere oplysninger om transaktionen/transaktionerne: gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktionera)Beskrivelse af det finansielle instrument, instrumenttypen IdentifikationskodeTegningsoption

Bavarian Nordic iværksætter nyt incitamentsprogram for koncernledelsen og udvalgte medarbejdere8.12.2022 21:35:00 CET | pressemeddelelse

KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen har besluttet at udstede tegningsoptioner til koncernledelsen og udvalgte medarbejdere i Bavarian Nordic koncernen. Som et nyt initiativ vil erhvervelsen (vesting) af tegningsoptioner for medlemmer af koncernledelsen være baseret på succesfuld opnåelse af relevante Key Performance Indicators (KPI’er). Beslutningen er truffet i henhold til generalforsamlingens bemyndigelser til bestyrelsen, jf. vedtægternes § 5b og 5c, og i overensstemmelse med selskabets vederlagspolitik. Der tildeles i alt 248.787 tegningsoptioner til medlemmer af koncernledelsen til en udnyttelseskurs på DKK 224,70 pr. aktie, svarende til markedskursen for Bavarian Nordics aktie på tildelingstidspunktet. Erhvervelse af tegningsoptionerne er betinget af forudgående opfyldelse af KPI’er, som fastsættes af bestyrelsen. Der tildeles i alt 683.264 tegningsoptioner til udvalgte medarbejdere i Bavarian Nordic koncernen til